4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
RACECADOTRIL - A NOVEL DRUG FOR TREATMENT OF ACUTE WATERY DIARRHEA IN INDIAN CHILDREN

Dr. M. R. Savita, G.M.C., Mysore



Introduction:


      Acute diarrheal disorder is the leading cause of mortality and morbidity in children under 5 years of age in developing countries. Racecadotril is being proposed as a new "WONDER" drug in management of acute watery diarrhea in children.

Objective:


      To assess the efficacy and adverse effects profile of Racecadotril in Indian children with acute watery diarrhea.

Design:


      Double blind, randomized placebo controlled clinical trial.

Setting:


      Urban teaching hospital and a referral center.

Subjects:


      Children aged less than or equal to 5 years with acute diarrheal disorder.

Methods:


      60 Children aged less than or equal to 5 years with acute diarrheal disorder of 5 days duration or less, were randomized into Racecadotril group (n = 30) or placebo group (n = 30) in addition to oral rehydration therapy. The mean duration of diarrhea and vomiting after randomization, total ORS intake and time taken for correction of dehydration were assessed.

Results:


       The baseline characteristics before randomization were comparable between Racecadotril and placebo group. Racecadotril group had a significant reduction in duration of diarrhea [40 hrs Vs 61.6 hrs in placebo group, p<0.01] and total ORS intake [841.67 ml Vs 1385 ml in placebo group, 'P' < 0.001] No adverse effects were documented in the Racecadotril group.

Conclusion:


      This study demonstrated that Racecadotril therapy is effective and safe in the management of acute watery diarrhea in children.


Last Updated on 01-1-2006

How to cite this url
Karnataka Pedicon 2005 - Conference Abstracts.Pediatric Oncall [serial online] 2006 [cited 01 January 2006];3. Available from:
http://www.pediatriconcall.com/fordoctor/Conference_abstracts/
racecadotrial.asp
 
 
 
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us